ConvaTec Group PLC (LON:CTEC)‘s stock had its “neutral” rating reissued by equities researchers at Citigroup Inc. in a research report issued to clients and investors on Wednesday. They presently have a GBX 290 ($3.81) price objective on the stock. Citigroup Inc.’s price target suggests a potential upside of 2.95% from the company’s previous close.
A number of other research analysts have also recently issued reports on the company. Numis Securities Ltd cut ConvaTec Group PLC to a “reduce” rating and cut their price target for the company from GBX 276 ($3.63) to GBX 260 ($3.42) in a report on Tuesday, July 11th. Goldman Sachs Group, Inc. (The) reaffirmed a “buy” rating and issued a GBX 340 ($4.47) price target on shares of ConvaTec Group PLC in a report on Friday, June 30th. Peel Hunt reaffirmed a “buy” rating and issued a GBX 380 ($5.00) price target on shares of ConvaTec Group PLC in a report on Thursday, July 20th. J P Morgan Chase & Co reaffirmed an “overweight” rating and issued a GBX 303 ($3.98) price target on shares of ConvaTec Group PLC in a report on Wednesday, September 20th. Finally, Deutsche Bank AG reaffirmed a “buy” rating and issued a GBX 330 ($4.34) price target on shares of ConvaTec Group PLC in a report on Monday, July 31st. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and six have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of GBX 309.60 ($4.07).
ConvaTec Group PLC (LON CTEC) opened at 281.70 on Wednesday. The firm’s market cap is GBX 5.50 billion. ConvaTec Group PLC has a 1-year low of GBX 213.00 and a 1-year high of GBX 349.10. The firm’s 50-day moving average is GBX 276.32 and its 200 day moving average is GBX 296.64.
COPYRIGHT VIOLATION NOTICE: This report was posted by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this report on another publication, it was illegally stolen and republished in violation of US and international trademark & copyright law. The original version of this report can be accessed at https://sportsperspectives.com/2017/10/11/convatec-group-plcs-ctec-neutral-rating-reaffirmed-at-citigroup-inc.html.
About ConvaTec Group PLC
ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.
Receive News & Ratings for ConvaTec Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.